In addition, when comparing the medical treatments received by thepatients between the groups, the use of angiotensin-converting enzyme inhibitors/angiotensin receptorblockers (ACE-I/ARB), calcium channel blockers (CCB) and beta-blockers (BB) wassimilar, whereas the use of acetylsalicylic acid (ASA) and statins was considerably greater inthe T2DM group. This evidence concerns the gene ACE and type 2 diabetes mellitus.